Note that the cytotoxicity of PRMT inhibitors, especially inhibitors for PRMT5, are shown to be more specific towards cancer cells because of PRMT overexpression in cancer tissues and the reliance of tumor cells on PRMT activity [127]. The gene discussed is PRMT5; the disease is cancer.